Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02367170Phase 2Terminated
Phase 2, randomised, single-blind trial (2 arms), sponsored by University of Florida. Primary endpoint: Change in Diaphragm Strength From Baseline at Day 28. Started Mar 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02367170.